USANA Health Sciences market cap is $1.6 b, and annual revenue was $1.06 b in FY 2019

USANA Health Sciences Gross profit (FY, 2019)873.4 M

USANA Health Sciences Gross profit margin (FY, 2019), %82.3%

USANA Health Sciences Net income (FY, 2019)100.5 M

USANA Health Sciences EBIT (FY, 2019)146.2 M

USANA Health Sciences Cash, 28-Dec-2019234.8 M

USANA Health Sciences revenue was $1.06 b in FY, 2019

USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
---|---|---|---|---|---|---|---|---|---|

## Revenue | 581.9m | 648.7m | 718.2m | 790.5m | 918.5m | 1.0b | 1.0b | 1.2b | 1.1b |

| 10% | 16% | 10% | ||||||

## Cost of goods sold | 101.7m | 115.8m | 127.4m | 140.8m | 159.7m | 180.2m | 179.4m | 200.7m | 187.5m |

## Gross profit | 480.2m | 532.9m | 590.7m | 649.7m | 758.8m | 825.9m | 867.9m | 988.5m | 873.4m |

| 83% | 82% | 82% | 82% | 83% | 82% | 83% | 83% | 82% |

## Sales and marketing expense | 3.9m | ||||||||

## R&D expense | 4.7m | ||||||||

## General and administrative expense | 137.1m | 154.2m | 166.2m | 234.2m | 265.1m | 275.1m | 267.7m | ||

## Operating expense total | 403.0m | 434.7m | 474.0m | 687.3m | 735.4m | 800.2m | 727.2m | ||

## Depreciation and amortization | 1.5m | ||||||||

## EBIT | 77.3m | 98.2m | 116.7m | 116.1m | 141.7m | 138.6m | 132.5m | 188.4m | 146.2m |

| 13% | 15% | 16% | 15% | 15% | 14% | 13% | 16% | 14% |

## Interest expense | 9.0k | 20.0k | 131.0k | 129.0k | 15.0k | 70.0k | 2.1m | 3.2m | 4.3m |

## Interest income | 191.0k | 247.0k | 464.0k | 500.0k | 1.1m | 1.5m | 2.2m | 4.4m | 4.7m |

## Pre tax profit | 77.5m | 98.4m | 116.6m | 115.7m | 142.6m | 138.6m | 134.6m | 191.5m | 150.5m |

## Income tax expense | 26.7m | 32.0m | 37.6m | 39.0m | 47.9m | 38.5m | 72.1m | 65.3m | 50.0m |

## Net Income | 50.8m | 66.4m | 79.0m | 76.6m | 94.7m | 100.0m | 62.5m | 126.2m | 100.5m |

USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
---|---|---|---|---|---|---|---|---|---|

## Cash | 50.4m | 70.8m | 137.3m | 111.1m | 143.2m | 175.8m | 247.1m | 214.3m | 234.8m |

## Accounts Receivable | 3.4m | ||||||||

## Prepaid Expenses | 18.7m | 25.2m | 35.8m | 30.1m | 32.5m | 25.5m | |||

## Inventories | 37.0m | 36.5m | 47.2m | 45.2m | 66.1m | 64.8m | 62.9m | 81.9m | 68.9m |

## Current Assets | 106.1m | 132.5m | 229.0m | 190.9m | 244.3m | 277.9m | 340.2m | 392.3m | 329.3m |

## PP&E | 60.8m | 61.8m | 59.2m | 71.2m | 88.0m | 101.3m | 102.8m | 92.0m | 95.2m |

## Goodwill | 17.7m | 17.9m | 18.2m | 17.9m | 17.4m | 16.7m | 17.4m | 16.8m | 16.6m |

## Total Assets | 244.5m | 267.4m | 368.5m | 350.6m | 423.2m | 470.6m | 519.3m | 554.5m | 516.9m |

## Accounts Payable | 8.0m | 7.0m | 9.5m | 7.8m | 10.0m | 9.0m | 11.8m | 9.9m | 12.5m |

## Short-term debt | 2.7m | ||||||||

## Current Liabilities | 59.7m | 70.8m | 95.9m | 108.7m | 131.4m | 138.5m | 141.2m | 148.7m | 136.1m |

## Long-term debt | 60.0m | ||||||||

## Total Debt | 62.7m | ||||||||

## Common Stock | 15.0k | 14.0k | 14.0k | 24.0k | 24.0k | 22.0k | |||

## Additional Paid-in Capital | 49.3m | 43.8m | 54.7m | 61.6m | 69.7m | 71.5m | 76.5m | 72.0m | 59.4m |

## Retained Earnings | 118.8m | 134.8m | 200.0m | 166.4m | 214.9m | 265.4m | 288.1m | 329.5m | 306.1m |

## Total Equity | 173.9m | 185.6m | 260.5m | 230.2m | 280.9m | 325.3m | 363.2m | 391.1m | 351.7m |

## Debt to Equity Ratio | 0.3 x | ||||||||

## Debt to Assets Ratio | 0.2 x | ||||||||

## Financial Leverage | 1.4 x | 1.4 x | 1.4 x | 1.5 x | 1.5 x | 1.4 x | 1.4 x | 1.4 x | 1.5 x |

USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
---|---|---|---|---|---|---|---|---|---|

## Net Income | 50.8m | 66.4m | 79.0m | 76.6m | 94.7m | 100.0m | 62.5m | 126.2m | 100.5m |

## Depreciation and Amortization | 8.5m | 8.8m | 9.0m | 8.8m | 10.0m | 13.5m | 16.1m | 16.8m | 14.7m |

## Accounts Receivable | |||||||||

## Inventories | (3.2m) | 1.4m | (11.8m) | 1.1m | (23.0m) | (1.0m) | 6.1m | (23.1m) | 13.0m |

## Accounts Payable | 1.5m | (985.0k) | 2.8m | (1.3m) | 2.5m | (1.3m) | 3.0m | (1.7m) | 1.8m |

## Cash From Operating Activities | 70.1m | 92.8m | 98.9m | 105.2m | 111.5m | 137.0m | 123.8m | 152.1m | 126.7m |

## Purchases of PP&E | (10.6m) | (8.4m) | (8.1m) | (20.4m) | (23.7m) | (32.7m) | (13.2m) | (11.4m) | (16.6m) |

## Cash From Investing Activities | (10.6m) | (8.3m) | (21.6m) | (16.3m) | (25.1m) | (31.9m) | (12.9m) | (69.0m) | 47.5m |

## Short-term Borrowings | (1.8m) | (73.7m) | (3.5m) | (5.0m) | |||||

## Cash From Financing Activities | (33.4m) | (64.5m) | (10.2m) | (113.0m) | (49.2m) | (64.9m) | (50.3m) | (105.3m) | (152.1m) |

## Net Change in Cash | 26.1m | 20.5m | 66.5m | 32.6m | 71.4m | (33.3m) | 20.5m | ||

## Interest Paid | 10.0k | 20.0k | 1.0k | 136.0k | 15.0k | 323.0k | 16.0k | 6.0k | 11.0k |

## Income Taxes Paid | 24.5m | 27.1m | 27.0m | 27.0m | 35.8m | 52.6m | 46.0m | 70.7m | 54.9m |

USD | Q2, 2012 |
---|---|

## Financial Leverage | 1.4 x |